Fiera Capital Corp - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Fiera Capital Corp ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,586,888
-24.6%
59,0580.0%0.01%
-16.7%
Q2 2023$2,106,008
+40.5%
59,058
+0.1%
0.01%
+50.0%
Q1 2023$1,499,312
-96.6%
59,028
-94.6%
0.00%
-97.1%
Q4 2022$43,953,047
+32.2%
1,083,655
-1.0%
0.14%
+15.1%
Q3 2022$33,242,000
-15.6%
1,094,692
-2.2%
0.12%
+1.7%
Q2 2022$39,402,000
-24.7%
1,119,063
-1.6%
0.12%
-14.0%
Q1 2022$52,322,000
-31.5%
1,137,688
-1.3%
0.14%
-24.0%
Q4 2021$76,429,000
+2.3%
1,152,769
-3.7%
0.18%
-6.8%
Q3 2021$74,721,000
-25.7%
1,196,891
-1.5%
0.19%
-25.6%
Q2 2021$100,623,000
+21.6%
1,214,964
-2.6%
0.26%
+8.4%
Q1 2021$82,743,000
-15.4%
1,247,814
-2.2%
0.24%
-9.5%
Q4 2020$97,857,000
+82.1%
1,275,339
+2.2%
0.26%
+64.4%
Q3 2020$53,745,000
-3.5%
1,248,140
-3.2%
0.16%
-14.9%
Q2 2020$55,711,000
+45.4%
1,289,902
-3.1%
0.19%
+17.5%
Q1 2020$38,308,000
-55.8%
1,331,527
-2.5%
0.16%
-44.6%
Q4 2019$86,610,000
+109.1%
1,365,446
-7.1%
0.29%
+87.7%
Q3 2019$41,416,000
+4.1%
1,469,696
-2.1%
0.15%
+2.0%
Q2 2019$39,797,000
+39.5%
1,501,789
-3.4%
0.15%
+36.0%
Q1 2019$28,538,000
+45.6%
1,555,255
-1.4%
0.11%
+24.7%
Q4 2018$19,596,0001,577,7710.09%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders